Cargando…

The impact of the COVID-19 epidemic on tuberculosis control in China

BACKGROUND: In response to the COVID-19 epidemic, China implemented a series of interventions that impacted tuberculosis (TB) control in the country. METHODS: Based on routine surveillance data and questionnaires, the study analyzed TB notification, follow-up examinations, and treatment outcomes. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fei, Huang, Yinyin, Xia, Hui, Chen, Ni, Wang, Xin, Du, Wei, Chen, Tao, Li, Shitong, Huan, Miaomiao, Sun, Mingting, Chen, Keshavjee, Salmaan, Yanlin, Zhao, Chin, Daniel P., Jianjun, Liu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7511841/ https://www.ncbi.nlm.nih.gov/pubmed/34173601 http://dx.doi.org/10.1016/j.lanwpc.2020.100032

Ejemplares similares

The Impact of COVID-19 on Tuberculosis Patients’ Behavior of Seeking Medical Care — China, 2020
por: Xia, Yinyin, et al.
Publicado: (2021)

Effectiveness of the Integrated TB Surveillance System — China, 2018–2019
por: Wang, Ni, et al.
Publicado: (2020)

Underreporting of Notifiable Pulmonary Tuberculosis Cases to the National Tuberculosis Information Management System — China, 2015
por: Li, Tao, et al.
Publicado: (2020)

Applying an Automated-Alert System for Tuberculosis Control in Schools in China
por: Cheng, Jun, et al.
Publicado: (2020)

Multichannel Financing Reduces Economic Burden and Improves the Medical Security Level for Tuberculosis Patients
por: Huang, Fei, et al.
Publicado: (2020)

Guiding Tuberculosis Control Through the Healthy China Initiative 2019−2030
por: Zhang, Hui, et al.
Publicado: (2020)

Cost–effectiveness of a comprehensive programme for drug-resistant tuberculosis in China
por: Fitzpatrick, Christopher, et al.
Publicado: (2015)

Tuberculosis in Schools and Requirements for Prevention and Control in China
por: Chen, Hui, et al.
Publicado: (2021)

Adverse Events Associated with Treatment of Multidrug-Resistant Tuberculosis in China: An Ambispective Cohort Study
por: Zhang, Yang, et al.
Publicado: (2017)

Guidelines for the Prevention and Control of Tuberculosis in Schools: Recommendations from China CDC
por: Xia, Yinyin, et al.
Publicado: (2021)

COVID-19 and Tuberculosis—A Global Tale of Hubris and Lessons Unlearned?
por: Drobniewski, Francis, et al.
Publicado: (2021)

Supporting a Comprehensive International Approach to Global Tuberculosis Eradication Is the Right Thing to Do
por: Burzynski, Joseph, et al.
Publicado: (2020)

Health systems performance in managing tuberculosis: analysis of tuberculosis care cascades among high-burden and non-high-burden countries
por: Kim, Jungyeon, et al.
Publicado: (2019)

Financial Burden of Tuberculosis Patients — China, 2020
por: Xu, Caihong, et al.
Publicado: (2023)

Accuracy of Commercial Molecular Diagnostics for the Detection of Pulmonary Tuberculosis in China: A Systematic Review
por: Deng, Siwei, et al.
Publicado: (2019)

Global Financing and Long-Term Technical Assistance for Multidrug-Resistant Tuberculosis: Scaling Up Access to Treatment
por: Hwang, Thomas J., et al.
Publicado: (2014)

Extensively Drug-Resistant Tuberculosis, Lesotho
por: Satti, Hind, et al.
Publicado: (2008)

A Questionnaire Survey on Extrapulmonary Tuberculosis Control and Prevention — China, 2021
por: Wang, Mingzhe, et al.
Publicado: (2023)

Age-Specific Pulmonary Tuberculosis Notification Rates — China, 2008–2018
por: Li, Tao, et al.
Publicado: (2022)

Patient, Diagnosis, and Treatment Delays Among Tuberculosis Patients Before and During COVID-19 Epidemic — China, 2018–2022
por: Li, Tao, et al.
Publicado: (2023)

Predicted Impact of the COVID-19 Responses on Deaths of Tuberculosis — China, 2020
por: Xu, Caihong, et al.
Publicado: (2021)

Tuberculosis/HIV Coinfection and Treatment Trends — China, 2015−2019
por: Liu, Eryong, et al.
Publicado: (2020)

Impact of latent tuberculosis infection on health and wellbeing: a systematic review and meta-analysis
por: Wong, Yen Jun, et al.
Publicado: (2021)

Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear–Negative Drug-Resistant Tuberculosis, China
por: Huang, Fei, et al.
Publicado: (2019)

Use of anti-tuberculosis drugs among newly diagnosed pulmonary tuberculosis inpatients in China: a retrospective study
por: Huang, Fei, et al.
Publicado: (2016)

Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China
por: Pang, Yu, et al.
Publicado: (2016)

Insight into the impact of the COVID-19 epidemic on tuberculosis burden in China
por: Chen, Hongguang, et al.
Publicado: (2020)

Diagnostic Value of Symptom Screening for Pulmonary Tuberculosis in China
por: Cheng, Jun, et al.
Publicado: (2015)

The effect of NCMS on catastrophic health expenditure and impoverishment from tuberculosis care in China
por: Zhou, Chengchao, et al.
Publicado: (2016)

Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment
por: Yuen, Courtney M, et al.
Publicado: (2015)

Diagnostic Accuracy of the PURE-LAMP Test for Pulmonary Tuberculosis at the County-Level Laboratory in China
por: Ou, Xichao, et al.
Publicado: (2014)

Implementation Performance of Tuberculosis Control in China: 2011–2020
por: Li, Tao, et al.
Publicado: (2021)

Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020–2021: Impact on medication adherence
por: Zhang, Mengxian, et al.
Publicado: (2023)

Facing the Challenge of Tuberculosis: Towards “End TB in China by 2035”
por: Zhao, Yanlin, et al.
Publicado: (2021)

Risk-benefit analysis of tuberculosis infection testing for household contact management in high-burden countries: a mathematical modelling study
por: Yuen, Courtney M, et al.
Publicado: (2020)

The Global Fund in China: Multidrug-resistant tuberculosis nationwide programmatic scale-up and challenges to transition to full country ownership
por: Wang, Lixia, et al.
Publicado: (2017)

Strengthening healthcare delivery with remote patient monitoring in the time of COVID-19
por: Mantena, Sreekar, et al.
Publicado: (2021)

Corrigendum: Digitizing tuberculosis treatment monitoring in Wuhan city, China, 2020–2021: Impact on medication adherence
por: Zhang, Mengxian, et al.
Publicado: (2023)

Is knowledge retained by healthcare providers after training? A pragmatic evaluation of drug-resistant tuberculosis management in China
por: Wu, Shishi, et al.
Publicado: (2019)

Health Facilities and Treatment Service Models of the National Tuberculosis Program — China, 2010−2020
por: Du, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iso4ahh1qg3q8lkfsk02rp1d56